IN PATIENTS WITH CORNEAL ABRASIONS TREATED WITH COLLAGEN CORNEAL SHIELDS IN THE EMERGENCY DEPARTMENT SETTING

by palligoelme@gmail.com | Nov 10, 2025 | Clinical Trials

​ Conditions: Corneal Abrasions Interventions: Device: Oasis 72-Hour collagen shield; Device: sham collagen shield Sponsors: Milton S. Hershey Medical Center Not yet recruiting Conditions: Corneal Abrasions Interventions: Device: Oasis 72-Hour collagen shield; Device:...

[Trial of device that is not approved or cleared by the U.S. FDA]

by palligoelme@gmail.com | Nov 10, 2025 | Clinical Trials

​ Sponsors: [Redacted] Withheld Sponsors: [Redacted] Withheld 

The Bridging Antiplatelet Therapy With Cangrelor 2 Study

by palligoelme@gmail.com | Nov 10, 2025 | Clinical Trials

​ Conditions: Coronary Arterial Disease (CAD) Interventions: Drug: Cangrelor Sponsors: University of Florida Not yet recruiting Conditions: Coronary Arterial Disease (CAD) Interventions: Drug: Cangrelor Sponsors: University of Florida Not yet...

Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

by palligoelme@gmail.com | Nov 10, 2025 | Clinical Trials

​ Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Diagnostic Test: Small RNA sequencing; Diagnostic Test: PRECEPT assay (qRT-PCR validation) Sponsors: City of Hope Medical Center Recruiting Conditions: Pancreatic Ductal Adenocarcinoma Interventions:...

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

by palligoelme@gmail.com | Nov 10, 2025 | Clinical Trials

​ Conditions: Advanced-stage Solid Tumors Interventions: Drug: JNJ-89862175 Sponsors: Janssen Research & Development, LLC Recruiting Conditions: Advanced-stage Solid Tumors Interventions: Drug: JNJ-89862175 Sponsors: Janssen Research & Development, LLC...